Cordaptive news from FiercePharma
NewsMerck layoffs inspire poets to versify
Curious what one laid-off Merck rep thinks about the Read more...
FDA panel rejects broader Fentora use
No go, Fentora. An FDA advisory panel voted against broadening the use of Cephalon's painkiller, Read more...
ALSO NOTED: China accuses U.S. of obstructing heparin probe; GSK exec charges Mass. with demonizing pharma;
> China continues to point fingers at the U.S. over the heparin investigation, saying the FDA refused to hand over details about patients who experienced severe allergic reactions to the blood Read more...
Where Merck loses, Abbott gains
What's bad for Merck is good for Abbott Labs. When the FDA said "no" to Read more...
Fissures in Merck, Schering relationship?
Are fault lines in the Merck/Schering-Plough joint venture beginning to open up? Market-watchers are reading the earnings-call transcripts--and the tea leaves--and finding evidence of "the Read more...
ALSO NOTED: FDA, Researchers butt heads over genetic screening;FDA approves Omrix's Evithrom;
> Perhaps this is a taste of genetic-screening battles to come: researchers at the University of North Carolina are questioning the FDA's genetic screening guidelines for the cancer drug Read more...
| Press ReleasesMerck Receives Not Approvable Letter from FDA for MK-0524A Merck Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant) WHITEHOUSE STATION, N.J., April 28, 2008 - Merck & Co., Inc. today received a Not Approvable action letter from Read more... PRESS RELEASE: Merck's "Good" Cholesterol Drug Meets Trial Goals Merck's "Good" Cholesterol Drug Meets Trial Goals WHITEHOUSE STATION, N.J.--Merck & Co., Inc. announced today Phase III clinical study results with CORDAPTIVE(TM) (ER niacin/ Read more... PRESS RELEASE: Merck Announces FDA Acceptance of NDA for CORDAPTIVE Merck Announces FDA Acceptance of NDA for CORDAPTIVE (ER niacin/laropiprant), Formerly Known as MK-0524A, an Investigational Lipid-Modifier WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. Read more... |
Get more Cordaptive coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight